James E. Flynn - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Catalyst Pharmaceuticals, Inc. (CPRX)

Filing Manager
Flynn James E
Reporting Manager
Deerfield Mgmt, L.P.
Security
Catalyst Pharmaceuticals, Inc. Common Stock
Symbol
CPRX
Shares outstanding
119M shares
Disclosed Ownership
3.13M shares
Ownership
2.63%
Form type
SCHEDULE 13G/A
Date filed
2/13/2025, 08:57 AM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 2.63% 3.13M 0 3.13M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 2.63% 3.13M 0 3.13M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 2.63% 3.13M 0 3.13M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 2.63% 3.13M 0 3.13M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact